Hepatic Encephalopathy
Hepatic Encephalopathy - Related Videos
01:29
Hepatic Encephalopathy
0 Views •
2026
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
08:47
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
0 Views •
Cited by 48 •
2008
The postnatal rat model for hypoxic-ischemic brain injury is a well-established model of human neonatal hypoxic ischemic encephalopathy (HIE). In this article, we describe the model of HIE in post-natal rat pups.
10:15
A Novel Method to Model Chronic Traumatic Encephalopathy in Drosophila
0 Views •
Cited by 19 •
2017
Here, we describe a new approach to inflict closed-head traumatic brain injury in Drosophila melanogaster. Our method has the advantage of directly delivering repetitive impacts with adjustable strength to the head alone. Further exploration of the invertebrate system will help to illuminate the pathogenesis of chronic traumatic encephalopathy.
10:30
A Piglet Model of Neonatal Hypoxic-Ischemic Encephalopathy
0 Views •
Cited by 37 •
2015
Hypoxic-ischemic encephalopathy following perinatal asphyxia can be studied using animal models. We demonstrate the procedures necessary for establishing a piglet model of neonatal hypoxic-ischemic encephalopathy.
09:35
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
0 Views •
Cited by 2 •
2017
Here we describe a newly developed hepatitis B virus (HBV) reporter system to monitor the early stages of the HBV life cycle. This simplified in vitro system will aid in the screening of anti-HBV agents using a high-throughput strategy.
FAQs
When liver dysfunction or portosystemic shunting reduces hepatic clearance, ammonia and other neurotoxic substances remain in the circulation. These substances affect astrocytes, the supportive brain cells involved in maintaining cerebral function, and alter neurotransmission. The resulting disruption helps explain why patients may develop impaired attention, behavioral changes, poor coordination, or altered consciousness.
Portosystemic shunting can allow blood from the gastrointestinal circulation to bypass normal hepatic processing. Neurotoxic substances therefore reach the systemic circulation despite the liver’s reduced opportunity to remove them. This mechanism is clinically important because hepatic encephalopathy may reflect not only impaired liver function, but also abnormal blood flow that limits hepatic clearance.
The disorder can present along a spectrum, beginning with subtle changes in cognition or attention and progressing to major disturbances in behavior, coordination, and consciousness. This range means that clinically important dysfunction may be present before coma develops. Careful observation of mental and neurological changes therefore supports earlier recognition and evaluation of worsening disease.
Infection, gastrointestinal bleeding, and medication effects are important precipitating factors to investigate when hepatic encephalopathy appears or worsens. These factors can accompany the underlying liver-related vulnerability and may contribute to changes in brain function. Identifying them is clinically relevant because evaluation should address both the neurological presentation and the potential trigger.
New or worsening abnormalities in attention, behavior, coordination, or consciousness should prompt clinical evaluation, particularly in a person with advanced liver disease or another context of impaired hepatic clearance. The pattern may range from subtle cognitive difficulty to coma. Recognizing these changes helps clinicians assess severity while investigating infection, gastrointestinal bleeding, medication effects, or other precipitating factors.
Hepatic encephalopathy illustrates how liver function, substances arising from the gut, and brain activity are interconnected. Reduced hepatic clearance permits neurotoxic substances to circulate and influence astrocytes, neurotransmission, and cerebral function. This perspective supports clinical strategies focused not only on recognizing episodes, but also on preventing recurrence and improving outcomes in advanced liver disease.